title: [Plasmodium ovale malaria severity].
authors.forename: B
authors.initials: B
authors.lastname: Rozé
authors.forename: Y
authors.initials: Y
authors.lastname: Lambert
authors.forename: E
authors.initials: E
authors.lastname: Gelin
authors.forename: F
authors.initials: F
authors.lastname: Geffroy
authors.forename: P
authors.initials: P
authors.lastname: Hutin
mesh_terms: D000328:Adult; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use; D002738:Chloroquine / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005869:Ghana / Q000208:ethnology; D006801:Humans; D008288:Malaria / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000469:parasitology; D008297:Male; D009549:Nigeria / Q000208:ethnology; D041122:Plasmodium ovale / Q000302:isolation & purification*; D011803:Quinine / Q000008:administration & dosage / Q000627:therapeutic use; D012121:Respiration, Artificial; D012128:Respiratory Distress Syndrome / Q000209:etiology* / Q000628:therapy
chemical_list: D000962:Antimalarials; D002738:Chloroquine; D011803:Quinine